Keyphrases
Causes of Mortality
33%
Cell Survival Pathways
33%
Clinical Application
33%
Drug Response
33%
Drug Sensitivity
33%
Endometrial Tumor
33%
Epithelial Ovarian Cancer
33%
Female Adults
33%
Genome Analysis
33%
Genome Complexity
33%
Genomic Profiling
33%
Gynecologic Malignancies
33%
Gynecological Cancer
100%
Gynecological Tumors
100%
Human Cervical Cancer
33%
Lineage-specific
33%
Metastasis
33%
Molecular Aberrations
33%
Molecular Characterization
33%
Molecular Determinants
33%
Molecular Targets
33%
Olaparib
33%
PARP Inhibitor (PARPi)
33%
Patient-derived Tumor Cells
100%
Patient-tailored Treatment
33%
Pharmacogenomics
33%
Pharmacological Analysis
100%
Pharmacological Drugs
33%
Precision Treatment
33%
Predictive Biomarker
33%
Rapid Drug Screening
33%
Sensitivity Method
33%
Simultaneous Activation
33%
Subcategorization
33%
Therapeutic Response
33%
TP53 mutation
33%
Transcriptome Expression
33%
Treatment Failure
33%
Treatment Regimen
33%
Treatment Response
33%
Tumor
33%
Tumor Cell Survival
33%
Tumorigenesis
33%
Uterine Sarcoma
33%
Medicine and Dentistry
Biological Marker
33%
Cancer
33%
Carcinogenesis
33%
Cell Survival
33%
Drug Response
33%
Drug Screening
33%
Drug Sensitivity
33%
Endometrium Tumor
33%
Female Genital Tract Cancer
100%
Female Genital Tract Tumor
100%
Krukenberg Tumor
33%
Metastatic Carcinoma
33%
Neoplasm
33%
Olaparib
33%
PARP Inhibitor
33%
Pharmacogenetic Testing
100%
Pharmacogenomics
33%
Transcriptome
33%
Treatment Response
66%
Tumor Cell
100%
Uterus Sarcoma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
33%
Carcinogenesis
33%
Drug Screening
33%
Endometrium Tumor
33%
Female Genital Tract Cancer
100%
Female Genital Tract Tumor
100%
Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
33%
Olaparib
33%
Ovary Carcinoma
33%
Pharmacogenomics
100%
Transcriptome
33%
Uterus Sarcoma
33%